Click on image to view larger version.

Figure 1 Survival free from all-cause mortality in the three cohorts in the Studies Of Left Ventricular Dysfunction (SOLVD) Prevention trial. The patients with ischemic cardiomyopathy and diabetes (n = 575; dashed line) had increased mortality compared with the patients with ischemic cardiomyopathy and no diabetes (n = 3,086; solid line) (p < 0.0001 by log-rank), but not significantly greater than that of the patients with nonischemic cardiomyopathy (n = 562; dotted line) (p = 0.21 by log-rank). The cohort with ischemic cardiomyopathy without diabetes (n = 3,086; solid line) demonstrated significantly lower mortality compared with the nonischemic cohort (p = 0.007 by log-rank) and the ischemic cohort with diabetes.